Desferal 500mg Vials Powder for Solution for Injection or Powder for Concentrate for Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

desferal 500mg vials powder for solution for injection or powder for concentrate for solution for infusion

novartis ireland limited - deferoxamine mesilate - powder for solution for injection/infusion - 500 milligram(s) - iron chelating agents; deferoxamine

QARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

qarziba dinutuximab beta 4.5 mg/ml concentrate for solution for infusion, 20 mg/4.5 ml vial

recordati rare diseases australia pty ltd - dinutuximab beta, quantity: 4.5 mg/ml - solution - excipient ingredients: polysorbate 20; hydrochloric acid; sucrose; water for injections; histidine - qarziba is indicated for the treatment of high-risk neuroblastoma in patients who have previously received induction chemotherapy and achieved at least a partial response.